enGene Holdings Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
8.52
-0.37 (-4.16%)
Nov 4, 2024, 4:00 PM EST - Market closed
enGene Holdings Employees
As of October 31, 2023, enGene Holdings had 33 total employees, including 31 full-time and 2 part-time employees.
Employees
33
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,740,485
Market Cap
376.72M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Oct 31, 2023 | 33 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cross Country Healthcare | 13,131 |
| Enhabit | 10,800 |
| Organogenesis Holdings | 862 |
| Sangamo Therapeutics | 405 |
| Amylyx Pharmaceuticals | 384 |
| AirSculpt Technologies | 381 |
| Esperion Therapeutics | 240 |
| Alpha Teknova | 211 |
ENGN News
- 11 days ago - enGene Announces $60 Million Private Placement Financing - Business Wire
- 13 days ago - enGene Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
- 14 days ago - enGene Appoints Joan Connolly as Chief Technology Officer and Anthony Cheung, Ph.D., as Chief Scientific Officer - Business Wire
- 4 weeks ago - enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
- 5 weeks ago - Detalimogene Demonstrates 71% Complete Response Rate at Any Time in Preliminary Analysis of LEGEND Pivotal Cohort - Business Wire
- 7 weeks ago - enGene Reports Third Quarter 2024 Financial Results and Provides a Business Update - Business Wire
- 2 months ago - enGene to Participate in Upcoming Investor Conferences - Business Wire
- 3 months ago - enGene Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Business Wire